Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
ill; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill) in a male patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The patient's past medical history included Liver transplantation. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine and Moderna COVID-19 vaccine. Past adverse reactions to the above products included No adverse effect with Moderna COVID-19 vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine and Moderna COVID-19 vaccine. On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In 2024, the patient experienced ILLNESS (ill). At the time of the report, ILLNESS (ill) outcome was unknown. For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. It was reported that the patient had received the COVID-19 vaccine doses with Moderna since 2020 except for last year due to illness. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-789732 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-789732:Master case
Medical History/Concurrent Conditions: Liver transplantation